Matt Pinfield shares an item he received from Ozzy Osbourne during his recovery from a stroke earlier this year that left him ...

AbbVie has launched its Produodopa therapy for Parkinson’s disease onto the market in the EU, becoming the first and only 24-hour levodopa-based subcutaneous infusion therapy for the ...

Armed with data from a small phase 1/2 bridging study, MeiraGTx is preparing to take its gene therapy for Parkinson's disease into a pivotal trial. Shares in the Anglo-US biotech rose sharply ...

According to the Parkinson’s Foundation, almost a million people in the United States live with Parkinson’s Disease, and in five years, it’s expected that number will reach 1.2 million. Keeping track ...